[HTML][HTML] Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?

M Martino, FA Canale, V Naso, G Porto… - International Journal of …, 2023 - mdpi.com
Allogeneic stem cell transplantation (allo-SCT) represented the first immunotherapy to treat
hematologic malignancies: it has been considered as a cure for the disease and never as an …

Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: A systematic review and meta-analysis

B Huang, J Shan, L Yi, Y Xin, Z Zhong, H Xu - Pediatric Nephrology, 2024 - Springer
Background Risk factors for acute kidney injury (AKI) in pediatric patients after hematopoietic
stem cell transplantation (HSCT) remain controversial. Objectives This study aimed to …

[HTML][HTML] Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions

P Sackstein, A Williams, R Zemel, JA Marks… - Biomedicines, 2024 - mdpi.com
The management of elderly patients diagnosed with acute myelogenous leukemia (AML) is
complicated by high relapse risk and comorbidities that often preclude access to allogeneic …

Reduced human leukocyte antigen mismatching is associated with more favourable outcomes after unrelated donor haematopoietic stem cell transplantation

B Valatkaite‐Rakstiene, R Cekauskiene… - International Journal …, 2024 - Wiley Online Library
The patient–donor human leukocyte antigen (HLA) match remains the most important
prognostic factor for successful unrelated donor haematopoietic stem cell transplantation …

[HTML][HTML] Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience

M McGuirk, M Shahzad, MK Amin, MA Khan… - Transplant …, 2024 - Elsevier
Background We aimed to investigate factors associated with cytomegalovirus (CMV) viremia
and CMV disease and its impact on post-transplant outcomes including overall survival (OS) …

[HTML][HTML] Multilocus HLA haplotypes (ABC-DRB1-DRB3/DRB4/DRB5-DQA1-DQB1-DPA1-DPB1) in families of patients scheduled for allogeneic hematopoietic stem …

EG Khamaganova, SP Khizhinskiy… - Medical Immunology …, 2023 - mimmun.ru
HLA haplotype is a block of HLA genes located on the same chromosome. Highly
polymorphic HLA genes display strong linkage disequilibrium, which results in conserved …

Choix d'un donneur non apparenté en vue d'une allogreffe de cellules souches hématopoïétiques: recommandations de la Société francophone de greffe de moelle et …

J Cornillon, R Crocchiolo, V Dubois, G Guidicelli… - Bulletin du …, 2024 - Elsevier
Résumé Le choix du donneur est un élément primordial dans la prise en charge d'un patient
pour une allogreffe de cellules souches hématopoïétiques. En l'absence de donneur familial …

[HTML][HTML] Мультилокусные HLA-гаплотипы (ABC-DRB1-DRB3/DRB4/DRB5-DQA1-DQB1-DPA1-DPB1) в семьях больных с назначением к трансплантации …

ЕГ Хамаганова, СП Хижинский… - Медицинская …, 2023 - mimmun.ru
Аннотация HLA-гаплотип–совокупность HLA-генов, лежащих на одной хромосоме.
Высокополиморфные HLA-гены демонстрируют выраженное неравновесное …

[HTML][HTML] Оптимальное мультилокусное HLA-типирование у потенциальных доноров аллогенных гемопоэтических стволовых клеток

ЕГ Хамаганова, СП Хижинский… - Клиническая …, 2023 - cyberleninka.ru
Актуальность. HLA-типирование и выбор совместимого донора имеют решающее
значение при трансплантации аллогенных гемопоэтических клеток (аллоТГСК), как и …

A Review on Donor Selection in Hematopoietic Stem Cell Transplantation (HSCT)

D Rashmi, C Kanmani - 2023 4th International Conference on …, 2023 - ieeexplore.ieee.org
In the healthcare industry today, machine learning techniques are extensively employed for
disease detection, prognosis, and therapy. These methods find use in the domain of …